EP3564233
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.8.2013EP published:
3.5.2023EP application number:
18209821.0
EPO information:
European Patent Register
Max expiry date:
12.8.2033
Title in English:
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONSLanguage of the patent:
English
Timeline
Today
13.8.2013EP application
3.5.2023EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CHEUNG, AtwoodAddress:
Cambridge, Massachusetts 02139, US
Name:
CHIN, Donovan NoelAddress:
Cambridge, Massachusetts 02139, US
Name:
DALES, NatalieAddress:
Cambridge, Massachusetts 02139, US
Name:
FAZAL, AleemAddress:
Cambridge, Massachusetts 02139, US
Name:
HURLEY, Timothy BrianAddress:
Cambridge, Massachusetts 02139, US
Name:
KERRIGAN, JohnAddress:
Cambridge, Massachusetts 02139, US
Name:
O'BRIEN, GaryAddress:
Cambridge, Massachusetts 02139, US
Name:
SHU, LeiAddress:
Cambridge, Massachusetts 02139, US
Name:
SUN, RobertAddress:
Natick, Massachusetts 01760, US
Name:
SUNG, MooAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
201261682448 PDate:
13.8.2012Country:
US
Classification
Categories:
C07D 401/14, C07D 405/14, C07D 413/14, C07D 401/12, C07D 403/14, C07D 409/14, C07D 417/14, C07D 471/04, C07D 471/08, C07D 487/04, C07D 487/10, A61K 31/501, A61P 21/00